{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:37:43Z","timestamp":1772213863763,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["5R01AR056019-13"],"award-info":[{"award-number":["5R01AR056019-13"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhsgo.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hand Surgery Global Online"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jhsg.2023.06.017","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:33:18Z","timestamp":1690882398000},"page":"682-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Let\u2019s Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-1931","authenticated-orcid":false,"given":"Alex G.","family":"Lambi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan T.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven N.","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prosper","family":"Benhaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhsg.2023.06.017_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249687","article-title":"Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action","volume":"16","author":"Karatzas","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jhsg.2023.06.017_bib2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhsg.2023.06.017_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/biom11081095","article-title":"Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis","volume":"11","author":"Tai","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jhsg.2023.06.017_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"Shih","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren\u2019s contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41-A","author":"Luck","year":"1959","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jhsg.2023.06.017_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.hcl.2018.03.001","article-title":"The basic science of Dupuytren disease","volume":"34","author":"Zhang","year":"2018","journal-title":"Hand Clin"},{"key":"10.1016\/j.jhsg.2023.06.017_bib7","doi-asserted-by":"crossref","unstructured":"Lambi AG, Popoff SN, Benhaim P, Barbe MF. Pharmacotherapies in Dupuytren\u2019s disease: current and novel strategies. J Hand Surg Am. Published online March 17, 2023. https:\/\/doi.org\/10.1016\/j.jhsa.2023.02.003","DOI":"10.1016\/j.jhsa.2023.02.003"},{"key":"10.1016\/j.jhsg.2023.06.017_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jclinepi.2003.11.015","article-title":"A\u00a0prospective study linked both alcohol and tobacco to Dupuytren\u2019s disease","volume":"57","author":"Godtfredsen","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/J.JHSE.2005.02.002","article-title":"An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren\u2019s disease in 97,537 miners","volume":"32","author":"Burke","year":"2007","journal-title":"J\u00a0Hand Surg Eur Vol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1302\/0301-620X.79B2.0790206","article-title":"Smoking, alcohol and the risk of Dupuytren\u2019s contracture","volume":"79","author":"Burge","year":"1997","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.jhsg.2023.06.017_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-0274(199605)29:5<521::AID-AJIM12>3.0.CO;2-2","article-title":"Can Dupuytren\u2019s contracture be work-related?: review of the evidence","volume":"29","author":"Liss","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.jhsg.2023.06.017_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0895-4356(99)00145-6","article-title":"Epidemiology of Dupuytren\u2019s disease: clinical, serological, and social assessment. The Reykjavik study","volume":"53","author":"Gudmundsson","year":"2000","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1302\/0301-620X.66B3.6725338","article-title":"Diabetes mellitus in the aetiology of Dupuytren\u2019s disease","volume":"66","author":"Noble","year":"1984","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.jhsg.2023.06.017_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94025-7","article-title":"Metabolic factors and the risk of Dupuytren\u2019s disease: data from 30,000 individuals followed for over 20 years","volume":"11","author":"Rydberg","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhsg.2023.06.017_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11552-010-9306-4","article-title":"Prevalence, incidence, and treatments of Dupuytren\u2019s disease in the United States: results from a population-based study","volume":"6","author":"Dibenedetti","year":"2011","journal-title":"Hand (N Y)"},{"key":"10.1016\/j.jhsg.2023.06.017_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib17","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2106\/00004623-198769090-00013","article-title":"Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease","volume":"69","author":"Tomasek","year":"1987","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.jhsg.2023.06.017_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib19","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1083\/jcb.98.6.2091","article-title":"In\u00a0vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface","volume":"98","author":"Singer","year":"1984","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.12.1.463","article-title":"Focal adhesions, contractility, and signaling","volume":"12","author":"Burridge","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib21","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1242\/jcs.114.18.3285","article-title":"Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors","volume":"114","author":"Dugina","year":"2001","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jhsg.2023.06.017_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mehy.2011.11.023","article-title":"Concurrent inhibition of TGF-beta and mitogen driven signaling cascades in Dupuytren\u2019s disease\u2014non-surgical treatment strategies from a signaling point of view","volume":"78","author":"Krause","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jhsg.2023.06.017_bib23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/BF02389692","article-title":"TGF beta and bFGF synthesis and localization in Dupuytren\u2019s disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin","volume":"27","author":"Berndt","year":"1995","journal-title":"Histochem J"},{"key":"10.1016\/j.jhsg.2023.06.017_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jcp.46.5.425","article-title":"Abnormal growth factor and cytokine expression in Dupuytren\u2019s contracture","volume":"46","author":"Baird","year":"1993","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","article-title":"The role of transforming growth factor beta in Dupuytren\u2019s disease","volume":"21","author":"Badalamente","year":"1996","journal-title":"J\u00a0Hand Surg Am"},{"key":"10.1016\/j.jhsg.2023.06.017_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","article-title":"The different characteristics of Dupuytren\u2019s disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1","volume":"28","author":"Bisson","year":"2003","journal-title":"J\u00a0Hand Surg Br"},{"key":"10.1016\/j.jhsg.2023.06.017_bib27","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target","volume":"110","author":"Verjee","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhsg.2023.06.017_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor beta and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren\u2019s disease fibroblasts","volume":"4","author":"Krause","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhsg.2023.06.017_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2474-5-41","article-title":"Enhanced Dupuytren\u2019s disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2","volume":"5","author":"Tse","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jhsg.2023.06.017_bib30","first-page":"189","article-title":"The connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed (CCN) family","volume":"20","author":"Brigstock","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhsg.2023.06.017_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12079-016-0360-8","article-title":"The pivotal role of CCN2 in mammalian palatogenesis","volume":"11","author":"Tarr","year":"2017","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.jhsg.2023.06.017_bib32","first-page":"18","article-title":"Development of normal and cleft palate: a central role for connective tissue growth factor (CTGF)\/CCN2","volume":"6","author":"Tarr","year":"2018","journal-title":"J\u00a0Dev Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i1.40","article-title":"The role of connective tissue growth factor (CTGF\/CCN2) in skeletogenesis","volume":"21","author":"Arnott","year":"2011","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.jhsg.2023.06.017_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/03008207.2020.1788546","article-title":"Blocking CCN2 preferentially inhibits osteoclastogenesis induced by repetitive high force bone loading","volume":"62","author":"Barbe","year":"2021","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib35","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/dvdy.23888","article-title":"The skeletal site-specific role of connective tissue growth factor in prenatal osteogenesis","volume":"241","author":"Lambi","year":"2012","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jhsg.2023.06.017_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12079-019-00542-6","article-title":"Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosis","volume":"13","author":"Leask","year":"2019","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.jhsg.2023.06.017_bib37","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhsg.2023.06.017_bib38","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/s41598-017-05624-2","article-title":"Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis","volume":"7","author":"Sakai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhsg.2023.06.017_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","article-title":"Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model","volume":"181","author":"Mori","year":"1999","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1165\/rcmb.2004-0158OC","article-title":"Connective tissue growth factor is crucial to inducing a profibrotic environment in \u201cfibrosis-resistant\u201d BALB\/c mouse lungs","volume":"31","author":"Bonniaud","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68-69","author":"Ramazani","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib42","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s11095-016-1918-0","article-title":"FG-3019, a human monoclonal antibody recognizing connective tissue growth factor, is subject to target-mediated drug disposition","volume":"33","author":"Brenner","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets","volume":"10","author":"Jun","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhsg.2023.06.017_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jhsg.2023.06.017_bib45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/13543784.2020.1773790","article-title":"Pamrevlumab for the treatment of idiopathic pulmonary fibrosis","volume":"29","author":"Sgalla","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jhsg.2023.06.017_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-017-1356-3","article-title":"Anti-connective tissue growth factor (CTGF\/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis","volume":"19","author":"Makino","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhsg.2023.06.017_bib47","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1093\/hmg\/ddt352","article-title":"Reducing CTGF\/CCN2 slows down mdx muscle dystrophy and improves cell therapy","volume":"22","author":"Morales","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhsg.2023.06.017_bib48","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jor.24337","article-title":"Blocking CCN2 reduces progression of sensorimotor declines and fibrosis in a rat model of chronic repetitive overuse","volume":"37","author":"Barbe","year":"2019","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12079-020-00568-1","article-title":"Slow train coming: an anti-CCN2 strategy reverses a model of chronic overuse muscle fibrosis","volume":"14","author":"Leask","year":"2020","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.jhsg.2023.06.017_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bone.2018.02.014","article-title":"Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism","volume":"110","author":"Barbe","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jhsg.2023.06.017_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2474-14-303","article-title":"The interaction of force and repetition on musculoskeletal and neural tissue responses and sensorimotor behavior in a rat model of work-related musculoskeletal disorders","volume":"14","author":"Barbe","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jhsg.2023.06.017_bib52","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1359\/jbmr.2003.18.11.2023","article-title":"Repetitive, negligible force reaching in rats induces pathological overloading of upper extremity bones","volume":"18","author":"Barr","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib53","article-title":"Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder","volume":"2011","author":"Driban","year":"2011","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jor.20984","article-title":"Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with\u00a0upper extremity repetitive strain injury","volume":"28","author":"Fedorczyk","year":"2010","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jcp.22208","article-title":"Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping","volume":"225","author":"Rani","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib56","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/jor.24709","article-title":"Blocking CTGF\/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse-induced median mononeuropathy","volume":"38","author":"Barbe","year":"2020","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.jhsg.2023.06.017_bib57","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1096\/fj.202000240RR","article-title":"Blocking CTGF\/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury","volume":"34","author":"Barbe","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jhsg.2023.06.017_bib58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10837450.2022.2038201","article-title":"Pirfenidone as a potential antifibrotic injectable for Dupuytren\u2019s disease","volume":"27","author":"Panigrahi","year":"2022","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.jhsg.2023.06.017_bib59","doi-asserted-by":"crossref","first-page":"822e","DOI":"10.1097\/PRS.0000000000000603","article-title":"Minimally invasive options in Dupuytren\u2019s contracture: aponeurotomy, enzymes, stretching, and fat grafting","volume":"134","author":"Murphy","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jhsg.2023.06.017_bib60","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jhsa.2012.04.026","article-title":"Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study","volume":"37","author":"McMillan","year":"2012","journal-title":"J\u00a0Hand Surg Am"}],"container-title":["Journal of Hand Surgery Global Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589514123001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589514123001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:59:12Z","timestamp":1762887552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589514123001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2589514123001123"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsg.2023.06.017","relation":{},"ISSN":["2589-5141"],"issn-type":[{"value":"2589-5141","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Let\u2019s Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target","name":"articletitle","label":"Article Title"},{"value":"Journal of Hand Surgery Global Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhsg.2023.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc. on behalf of The American Society for Surgery of the Hand.","name":"copyright","label":"Copyright"}]}}